-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
C4 Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q4 2024.
- C4 Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $3.27M, a 10.7% increase year-over-year.
- C4 Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $14.4M, a 84.6% increase year-over-year.
- C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $14.4M, a 84.6% increase from 2023.
- C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $7.82M, a 475% increase from 2022.
- C4 Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.36M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)